| Tue 12:45 |
|
RNS |
RNS Number : 9577W Ultrasis PLC 07 February 2012 |
| |
|
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
|
| 1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii | Ultrasis plc | 2 Reason for the notification (please tick the appropriate box or boxes): | An acquisition or disposal of voting rights | X | An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| An event changing the breakdown of voting rights |
| Other (please specify): |
|
| 3. Full name of person(s) subject to the
notification obligation: iii | Paul Anthony Bell (Fitel Nominees A/c 0060214) | 4. Full name of shareholder(s)
(if different from 3.):iv |
| 5. Date of the transaction and date on
which the threshold is crossed or
reached: v | 2 February 2012 | 6. Date on which issuer notified: | 2 February 2012 | 7. Threshold(s) that is/are crossed or
reached: vi, vii | 9.01% | | | | | | |
8. Notified details: | A: Voting rights attached to shares viii, ix | Class/type of
shares
if possible using
the ISIN CODE
| Situation previous
to the triggering
transaction | Resulting situation after the triggering transaction | Number
of
Shares | Number
of
Voting
Rights | Number
of shares | Number of voting
rights | % of voting rights x | Direct | Direct xi | Indirect xii | Direct | Indirect | GB0001494979 | 121,295,000 | 121,295,000 | 135,960,900 | 135,960,900 | N/A | 9.01 | N/A |
|
| B: Qualifying Financial Instruments | Resulting situation after the triggering transaction | Type of financial
instrument | Expiration
date xiii | Exercise/
Conversion Period xiv | Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted. | % of voting
rights |
|
|
|
|
|
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | Resulting situation after the triggering transaction | Type of financial
instrument | Exercise price | Expiration date xvii | Exercise/
Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx |
|
|
|
| | Nominal | Delta |
|
|
| Total (A+B+C) | Number of voting rights | Percentage of voting rights | 135,960,900 | 9.01% | | | | | | | | | | | | | | | | | |
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi | |
| Proxy Voting: | 10. Name of the proxy holder: |
| 11. Number of voting rights proxy holder will cease
to hold: |
| 12. Date on which proxy holder will cease to hold
voting rights: |
|
|
13. Additional information:
|
| 14. Contact name: | Barrie Tyler, WH Ireland Limited | 15. Contact telephone number: | 02920 729001 | | | |
This information is provided by RNS
The company news service from the London Stock Exchange END HOLSSEFEWFESEDE
More
|
| 01-02-12 |
|
RNS |
RNS Number : 6071W Ultrasis PLC 01 February 2012 1 February 2012 Ultrasis plc ("Ultrasis" or the "Company") Issue of Shares under Share Incentive Plan Ultrasis, the provider of interactive health care services, today announces the issue of 1,430,757 new ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") under its Share Incentive Plan ("SIP"), which was previously announced on 18 October 2011. As participants in the SIP and Directors of the Company, Nigel Brabbins (Chief Executive) and John Smith (Sales Director) have, as required by the AIM Rules, notified the Company that they acquired the following Ordinary Shares ("Partnership Shares") and have been conditionally awarded the following Ordinary Shares ("Matching Shares"), under the terms of the SIP and at a price of 0.585p each (being the lower of the price at the start of the accumulation period and the price on the acquisition date as set out in the HMRC approved SIP rules):
| No. of Partnership Shares | Purchase price | No. of Matching Shares | Purchase price | Nigel Brabbins | 64,102 | 0.585p | 128,204 | 0.585p | John Smith | 64,102 | 0.585p | 128,204 | 0.585p |
The SIP is open to all employees on the same terms where, for every Ordinary Share purchased by an employee, the Company will match it with two Matching Shares. The Matching Shares are released at the end of a three year holding period (subject to the SIP rules) and the maximum amount that may be invested in Partnership Shares in any tax year is £1,500 per employee. Nigel Brabbins and John Smith have each committed to invest the maximum of £125 per month. Following this transaction, Nigel Brabbins and John Smith now hold the following Ordinary Shares, together with options over the same (including Matching Shares) and exercisable at various prices up to 1.35 pence, as follows:
| No. of Ordinary Shares | No. of options | | | | Nigel Brabbins | 1,192,306 | 58,666,667 | John Smith | 308,046 | 17,666,667 |
Application has been made for the 1,430,757 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is anticipated to occur on 7 February 2012. For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares in issue following Admission will be 1,509,284,015, each carrying the right to one vote. The above figure of 1,509,284,015 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Ultrasis under the FSA's Disclosure and Transparency Rules. For further information contact: Ultrasis plc Nigel Brabbins, CEO | Tel: +44 (0) 20 7535 2050 | Strand Hanson Limited Stuart Faulkner / Liam Buswell | Tel: +44 (0) 20 7409 3494 | JBP Public Relations | Tel: +44 (0) 11 7907 3400 |
Chris Lawrance
This information is provided by RNS
The company news service from the London Stock Exchange END RDSLLFSFFAILIIF
More
|
| 27-01-12 |
|
RNS |
RNS Number : 2897W Ultrasis PLC 27 January 2012 27 January 2012 Ultrasis plc ("Ultrasis" or the "Company") Result of Annual General Meeting Ultrasis announces that, at its Annual General Meeting ("AGM") held yesterday, Resolutions 1, 3 and 4 were duly passed and Resolutions 2, 5 and 6 were not passed. Valid proxies were lodged in respect of 487,154,710 ordinary shares in the capital of the Company, as follows:
| For | Against | Abstain | Result | Resolution 1 | 486,679,633 | 296,145 |
| 178,932 | Pass | Resolution 2 | 225,433,540 | 261,129,549 |
| 591,621 | Fail | Resolution 3 | 409,838,483 | 77,255,996 | 60,231 | Pass | Resolution 4 | 485,421,251 | 273,059 | 1,460,400 | Pass | Resolution 5 | 194,459,362 | 292,287,825 | 407,523 | Fail | Resolution 6 | 192,571,437 | 232,274,148 | 12,309,125 | Fail |
The AGM Circular and Notice of AGM, which include details of the above mentioned resolutions, are available to view on Ultrasis' website, www.ultrasis.com. For further information contact: Ultrasis plc Nigel Brabbins, CEO | Tel: +44 (0) 20 7535 2050 | Strand Hanson Limited Stuart Faulkner / Liam Buswell | Tel: +44 (0) 20 7409 3494 | JBP Public Relations | Tel: +44 (0) 11 7907 3400 |
Chris Lawrance
This information is provided by RNS
The company news service from the London Stock Exchange END RAGEDLBLLFFEBBZ
More
|
| 26-01-12 |
|
RNS |
RNS Number : 1435W Ultrasis PLC 26 January 2012 26 January 2012 Ultrasis plc ("Ultrasis" or the "Company") First customer for US version of Beating the Blues Ultrasis, the provider of interactive healthcare services, is pleased to announce that its joint venture with UPMC, U² Interactive, has successfully secured its first contract in the United States with MultiCare Health System ("MultiCare"). Multicare provides a comprehensive network of services throughout Pierce, South King, Thurston and Kitsap counties in the State of Washington and will make the US version of Beating the Blues ("BtB US") available across their entire portfolio of community and hospital based behavioural health services. Sue Miller from MultiCare Good Samaritan, said: "We are delighted to be working in partnership with U² Interactive to make Beating the Blues available within our services. We are always looking for affordable and evidence based ways to increase access to treatment for our populations." Nigel Brabbins Chief Executive of Ultrasis said: "I am delighted that we have secured this contract with Multicare, it has been only three months since we completed the development of BtB US and to secure our first contract so soon is a great achievement." "The sales team at U² Interactive are working on a number of opportunities and I am certain that this will be the first of many such contracts." For further information contact: Ultrasis plc Nigel Brabbins, CEO | Tel: +44 (0) 20 7535 2050 | Strand Hanson Limited Stuart Faulkner / Liam Buswell | Tel: +44 (0) 20 7409 3494 | JBP Public Relations Chris Lawrance | Tel: +44 (0) 117 907 3400 |
About U² Interactive U² Interactive is the joint venture, announced in September 2011, between Ultrasis and UPMC, a US$9 billion Integrated Healthcare Provider based in Pittsburgh, Pennsylvania. For more information on U² Interactive please visit: www.u2interactive.com About MultiCare MultiCare is a not-for-profit health care organization with more than 9,300 employees and a comprehensive network of services throughout Pierce, South King, Thurston and Kitsap counties. MultiCare is made up of four hospitals including Allenmore Hospital, Good Samaritan Hospital, Mary Bridge Children's Hospital and Tacoma General Hospital, numerous outpatient specialty centres, primary and urgent care clinics, as well as a variety of other services, including comprehensive mental health services and community outreach programs. For more information on MultiCare please visit: www.multicare.org
This information is provided by RNS
The company news service from the London Stock Exchange END MSCBKPDKKBKDODB
More
|
